SGLT2 inhibitors and kidneys: mechanisms and main effects in diabetes mellitus patients
Type 2 diabetes mellitus (T2DM) is the cause of the development of diabetic nephropathy — a complication that determines the high degree of disability and mortality of such patients. Until recently, approaches to normalizing glucose levels did not have a significant possibility of influencing the ou...
Saved in:
| Main Authors: | Vladimir V Salukhov, Yurii Sh. Khalimov, Sergey B. Shustov, Sergey I. Popov |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Endocrinology Research Centre
2021-01-01
|
| Series: | Сахарный диабет |
| Subjects: | |
| Online Access: | https://www.dia-endojournals.ru/jour/article/view/12123 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Sodium-glucose cotransporter 2 inhibitor for the treatment of diabetic nephropathy
by: Kong Ling-li, et al.
Published: (2021-01-01) -
Progress in studies on renal effects and molecular mechanism of SGLT-2 inhibitors
by: XING Bei, et al.
Published: (2020-01-01) -
EFFICACY OF SGLT-2 INHIBITORS IN THE TREATMENT OF TYPE 2 DIABETES: SINGLE CENTRE EXPERIENCE
by: Ramazan Çakmak, et al.
Published: (2025-01-01) -
Early Introduction of SGLT-2 Inhibitors to Improve Chronic Kidney Disease Care in People with or without Diabetes—Consensus by Indian Nephrologists
by: Manisha Sahay, et al.
Published: (2025-04-01) -
Relationship between low glomerular filtration rate, hypertension, and microalbuminuria in type 1 diabetes mellitus
by: Vasović Olga, et al.
Published: (2005-01-01)